Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RORC | P51449 | 1/20 | 0.34 |
| ▸ | CNR2 | P34972 | 5/20 | 0.31 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.30 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.30 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20547209 | 0.88 | KCNH2 (0.32) | RORCKCNH2 | |
| SCHEMBL21949322 | 0.88 | KCNH2 (0.32) | RORCKCNH2 | |
| SCHEMBL21948583 | 0.86 | KCNH2 (0.32) | RORCKCNH2 | |
| SCHEMBL21948704 | 0.84 | RORC (0.32) | RORCCNR2 | |
| SCHEMBL21948872 | 0.83 | ADORA2A (0.33) | RORCCNR2KCNH2 | |
| SCHEMBL24361061 | 0.80 | RORC (0.32) | RORCKCNH2 | |
| SCHEMBL21948991 | 0.80 | KCNH2 (0.32) | RORCKCNH2 | |
| SCHEMBL19299809 | 0.80 | RORC (0.34) | RORCCNR2KCNH2 | |
| SCHEMBL18179708 | 0.80 | RORC (0.33) | RORCCNR2KCNH2CYP11B1CYP11B2 | |
| SCHEMBL21875179 | 0.79 | KCNH2 (0.33) | RORCCNR2KCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20200128830-A1 | FUSED BICYCLIC HETEROCYCLE DERIVATIVES AS PESTICIDES | BAYER AKTIENGESELLSCHAFT (DE) | 2020-04-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200128830-A1 | FUSED BICYCLIC HETEROCYCLE DERIVATIVES AS PESTICIDES | DDT, ACHE, BCHE | RORC 3617/4885CNR2 183/4885KCNH2 747/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.